School of Nursing, Jilin University, Changchun, Jilin 130021, China.
The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Biomed Res Int. 2019 May 19;2019:3753786. doi: 10.1155/2019/3753786. eCollection 2019.
Hyposmia is one of the most common and best-characterized conditions that is also one of the first nonmotor features of Parkinson's disease (PD). The association of hyposmia with PD is widely accepted; however the likelihood of developing PD is unclear. Our meta-analysis aimed to investigate the risk of PD in individuals with hyposmia.
Prospective studies on humans published before December 4, 2018, were searched for in PubMed, Embase, Web of Science, and Cochrane Library databases. Two independent reviewers screened studies for inclusion and extracted data. We assessed the quality of studies using the Newcastle-Ottawa Scale and pooled data for analysis using random-effects models.
Of the 1774 studies retrieved, seven met the inclusion criteria for this review. A total of 3272 hyposmia and 176 PD events were reported over follow-up periods ranging from 3 to 17 years. Hyposmia was associated with a 3.84-fold risk of developing PD (pooled relative risk: 3.84, 95% CI 2.12-6.95). Subgroup analyses identified few differences between different hyposmia assessment methodologies and follow-up periods.
Our findings suggest that deficiencies in olfaction are associated with an increased risk of developing PD. Future studies are needed to investigate whether hyposmia is a promising and feasible biomarker for the early diagnosis of PD.
嗅觉减退是最常见和特征最明显的疾病之一,也是帕金森病(PD)最早的非运动特征之一。嗅觉减退与 PD 的相关性已被广泛接受;然而,发展为 PD 的可能性尚不清楚。我们的荟萃分析旨在研究嗅觉减退个体患 PD 的风险。
在 PubMed、Embase、Web of Science 和 Cochrane Library 数据库中搜索了截至 2018 年 12 月 4 日之前发表的关于人类的前瞻性研究。两名独立的审查员筛选研究以纳入并提取数据。我们使用纽卡斯尔-渥太华量表评估研究质量,并使用随机效应模型汇总数据进行分析。
在检索到的 1774 篇研究中,有 7 篇符合本综述的纳入标准。在 3 至 17 年的随访期间,共报告了 3272 例嗅觉减退和 176 例 PD 事件。嗅觉减退与 PD 的发病风险增加 3.84 倍(汇总相对风险:3.84,95%CI 2.12-6.95)。亚组分析发现,不同的嗅觉减退评估方法和随访时间之间差异不大。
我们的研究结果表明,嗅觉功能障碍与 PD 的发病风险增加有关。需要进一步的研究来探讨嗅觉减退是否是 PD 早期诊断的一个有前途且可行的生物标志物。